Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jeffrey J. Buda
Observed names:
J Buda,
J. BUDA,
J. J. BUDA,
Jeffrey J Buda
Institution:
RTI International
Observed institutions:
RTI International,
RTI Health Solutions
OpenAlex ID:
A5043655827
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
2008
·
A. W. MANGEL
, J. D. BORNSTEIN
, et al.
·
Alimentary Pharmacology & Therapeutics
·
140
PDF
Determinants of healthcare‐seeking behaviour among subjects with irritable bowel syndrome
2006
·
R. E. WILLIAMS
, C. L. BLACK
, et al.
·
Alimentary Pharmacology & Therapeutics
·
75
Minimizing Resistance Consequences After Virologic Failure on Initial Combination Therapy: A Systematic Overview
2006
·
John A. Bartlett
, Jeffrey J. Buda
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
66
A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic
2015
·
Jeffrey J Buda
, F I Carroll
, et al.
·
Neuropsychopharmacology
·
60
PDF
Stability of irritable bowel syndrome using a Rome II‐based classification
2005
·
R. E. WILLIAMS
, C. L. BLACK
, et al.
·
Alimentary Pharmacology & Therapeutics
·
39
PDF
A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336
2018
·
F. Ivy Carroll
, Thomas R. Kosten
, et al.
·
Frontiers in Pharmacology
·
2
PDF
Follow-up of an IBS cohort describes instability of C-IBS and D-IBS subtypes after three years
2005
·
RE Williams
, SF Cook
, et al.
·
1
Population-based survey of people with IBS: Frequency vs. consistency of bowel symptoms and reasons for health care seeking
2005
·
RE Williams
, SF Cook
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
8
Citation count:
383
H-index:
5
I10-index:
5
Year
Topic
Type